Outpatient Parenteral Antibiotic Therapy (OPAT) Conference & Workshops

Part of the BSAC OPAT Initiative

Regional Workshop: Belfast

5th May 2020, Radisson Blu Hotel, Belfast

Local Facilitator and Chair:

Welcome and introduction
Eileen Dorgan, Consultant Microbiologist, Antrim Hospital, Northern Health and Social Care Trust
BSAC OPAT Initiative – where are we now?
Mark Gilchrist, Consultant Pharmacist Infectious Diseases, Imperial College Healthcare NHS Trust

Current Picture of OPAT in NI (PART 1)
Chair: Eileen Dorgan, Consultant Microbiologist, Antrim Hospital, Northern Health and Social Care Trust
ENCOMPASS from the South Eastern and Belfast Trust experiences
Peter Nelson, Consultant Microbiologist South Eastern Health and Social Care Trust
Paediatric OPAT in Belfast
Paul Moriarty Paediatric Infectious Diseases Consultant, Belfast Trust
OPAT in South Eastern Trust – Progress and Challenges
Cheryl Scott, Lead OPAT Pharmacist South Eastern Health and Social Care Trust


OPAT in Respiratory Cases (PART 2)
Chair: Louise McCorry, Infectious Diseases Consultant, Belfast Trust
Empyema Case
Kate Jackson, Specialist Trainee in Microbiology & Infectious Diseases Trainee, Belfast Trust
Aminoglycoside use with OPAT
Fiona Gilmore Lead OPAT Pharmacist Northern Trust
Case Review – to be confirmed
To be confirmed


Chair: Eileen Dorgan, Consultant Microbiologist, Antrim Hospital, Northern Health and Social Care Trust
Managing recurrent respiratory infections in patients with Bronchiectasis with OPAT
Doreen McGhee Respiratory Specialist Nurses Northern and Belfast Trust
Panel Discussion on the varying experiences of OPAT

Summary & closing remarks

Welcome and introduction
Evidence base for OPAT (GPR, NORS, Drug Stability) - Evidence, standards and outcomes: the trinity of successful OPAT
Local OPAT - Discussion point 1

Coffee break

Case Presentation 1
Case presentation 4
Panel discussion

Lunch and networking

Learning from OPAT Centres
Case presentation 3
Case Presentation 4
Local OPAT - Discussion point 2
Next steps
Summary of day / Closing Remarks


Professor Andrew Seaton

Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde, UK

Andrew graduated from Aberdeen in 1989 and trained in General Medicine/ infectious diseases in Dundee and Papua New Guinea. He was appointed consultant physician in Glasgow in 2000 and he is an Honorary Professor in the University of Glasgow. He established and leads the NHS Greater Glasgow and Clyde OPAT service and Antimicrobial Management Team. He Chairs the Scottish Antimicrobial Prescribing Group and is a member of the Scottish Government urgent and unscheduled care virtual capacity / hospital at home expert advisory group. He co-leads the BSAC OPAT initiative and co-produced the BSAC OPAT MOOC on future learn. He has >160 peer reviewed publications.


B. Braun

B. Braun is one of the world’s leading providers and manufacturers of healthcare solutions today.

Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the company’s deep understanding of users’ needs, and extensive expertise since 1839.

With its constantly growing portfolio of effective medical care solutions, B. Braun makes a substantial contribution towards protecting and improving people’s health.

By offering supplementary services and consulting, B. Braun is a system supplier that develops the best solution for patients in close partnership with our customers, making a

significant contribution to medical advancements.


System partnerships, relationships and earnings are the core themes which are to be pursued in all divisions and regions, with the support of the centralised units and departments.

The goal is to grow together in order to ensure that our company will be able to operate independently in the current strategic period. This will allow us in the future to continue making

a contribution to protecting and improving the health of people all over the world.

Visit sponsor website

BIOPATCH® is an antimicrobial sponge dressing providing 7-day release of Chlorhexidine Gluconate. It is indicated to reduce local infections, catheter-related blood stream infections (CRBSI), and skin colonization of microorganisms commonly related to CRBSI from vascular and non-vascular percutaneous devices. BIOPATCH® can help improve patient outcomes, reduce hospital costs and reduce CRBSIs.

Visit sponsor website
Horizon Strategic Partners

Horizon Strategic Partners (HSP) was established in 2008 to provide IT Consultancy Services to the Department of Health. Since then it has developed a range of mobile healthcare solutions that are used in over 50% of all UK Acute Hospital Trusts.

HSP has worked with the BSAC over a number of years on various IT projects, such as the development of the OPAT National Outcomes Registry which provides the most comprehensive overview of OPAT service provision in the UK. Recently HSP has worked with PHE to develop a Point Prevalence Survey (PPS) System that was used on a national basis to collect data for the 2016 ECDC survey of healthcare-associated infections and antimicrobial use in acute care hospitals.

In 2017 HSP took over the IPR and development of the OPAT Patient Management System (PMS), with an upgraded system being launched in 2018.

Visit sponsor website


Please submit your abstract(s) using the online submission form for consideration for POSTER presentation at the OPAT Workshops.

The deadline for abstract submission for the London, Bristol & Newmarket workshops is 1700hrs BST on Friday 16 August 2024.

Please note our Conditions of Submission:
1. The presenting author must register for their chosen workshop.
2. Abstracts must be submitted by the deadline.
3. The first author should ideally be the presenting author. All correspondence will be sent to the lead author.
4. If selected for poster presentation authors are required to submit their poster in pdf (landscape) format prior to the first workshop.
5. All abstracts need to be submitted using the online submission form.

Format of Abstracts:
Abstracts should be no longer than 400 words and contain:
• an initial statement of specific objectives of the study, unless this is given in the title;
• a brief statement of methods;
• a summary of the results obtained;
• specific conclusions.

For any queries regarding abstract submissions, please contact Esme Carruthers.


There are various sponsorship opportunities available to support this workshop series. Please contact Esme Carruthers for further details.